Arachidonyl ethanolamide (Anandamide) activates the parvocellular part of hypothalamic paraventricular nucleus

Biochemical and Biophysical Research Communications

Volumn 237, Issue 3, 1997, Pages 724-728

  Wenger, Tibor ^a   Jamali, Khalid A ^b   Juanéda, Christian ^b   Léonardelli, Jean ^c   Tramu, Gérard ^b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CANNABINOID RECEPTOR ANTAGONIST; ETHANOLAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; HORMONE BLOOD LEVEL; HYPOTHALAMUS; IMMUNOCYTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; THALAMUS MIDLINE NUCLEUS;

EID: 0031589566     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.7222     Document Type: Article

References (21)

1. Devane W. A., Hanuš L., Breuer A., Pertwee R. G., Stevenson L. A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Science. 258:1992;1946-1949.
2. Kulkarini S. K., Ninan I., George B. Drugs Today. 32:1996;275-285.
3. Pertwee R. G., Griffin G., Hanuš L., Mechoulam R. Eur. J. Pharmacol. 259:1994;115-120.
4. Herkenham M. Cannabinoid Receptors. 1995;Academic Press, London/San Diego. p. 145-166.
5. Felder C. C., Nielsen A., Briley E. M., Palkovits M., Priller J., Axelrod J., Nguyen D. N., Richerdson J. M., Riggin R. M., Koppel G. A., Paul S. M., Becker G. W. FEBS Letters. 393:1996;231-235.
6. Vogel Z., Barq J., Levy R., Saya D., Heldman E., Mechoulam R. J. Neurochem. 61:1993;352-355.
7. Perwee R. G. Pertwee R. G. Cannabinoid Receptors. 1995;1-34 Academic Press, London/San Diego.
8. Rinaldi-Carmona M., Barth F., Héaulme M., Alonso R., Shire D., Congy C., Soubrié P., Brelière J. C., LeFur G. Life Sci. 56:1995;1941-1947.
9. Weidenfeld J., Rougeot C., Dray F., Feldman S. Neurosci. Lett. 107:1989;189-194.
10. Antoni F. A. Endocr. Rev. 7:1983;351-377.
11. Puder M., Weidenfeld J., Chowers I., Nir J., Conforti N., Siegel R. A. Exp. Brain Res. 46:1982;85.
12. Weidenfeld J., Feldman S., Mechoulam R. Neuroendocrinology. 59:1994;110-112.
13. Hofman G. E., Smith M. S., Verdalis J. G. Ganong W. F., Martini L. Frontiers in Neuroendocrinology. 1993;173-213 Raven Press, New York.
14. Pape J. R., Ciofi P., Tramu G. J. Neuroendocrinol. 8:1996;375-386.
15. Kovács K. J., Makara G. B. Brain Res. 474:1988;205-210.
16. Deutsch D. G., Chin S. A. Biochem. Pharmacol. 46:1993;791-796.
17. Friede E., Mechoulam R. Eur. J. Pharmacol. 231:1993;313-314.
18. deFonesca F. R., Cebeira M., Ramos J. A., Martin M., Fernandez-Ruiz J. J. Life Sci. 54:1994;159-170.
19. Shivachar A. C., Martin B. R., Ellis E. F. Biochem. Pharmacol. 51:1996;669-676.
20. Venance L., Piomelli D., Glowinski J., Giaume C. Nature. 376:1995;590-594.
21. Pertwee R. G. Brit. J. Pharmacol. 51:1974;391-397.